alexa Bedside Alarmin: Neutrophil-to-Lymphocyte Ratio in Acute Kidney Injury | Open Access Journals
ISSN: 2161-0959
Journal of Nephrology & Therapeutics
Like us on:
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Bedside Alarmin: Neutrophil-to-Lymphocyte Ratio in Acute Kidney Injury

Devrim Bozkurt*, Dilara Kilic, Tugba Kip, Mehmet Berktas, Kilavuz Asli and Akcicek Fehmi

Internal Medicine, Ege University, Bornova, Izmir, 35100, Turkey.

*Corresponding Author:
Devrim Bozkurt
Associate Professor, Ege University
Internal Medicine Bornova
Izmir, 35100, Turkey
Tel: 00902323904287
E-mail: [email protected]

Received Date: May 30, 2016; Accepted Date: June 9, 2016; Published Date: June 26, 2016

Citation: Kilic D, Kip T, Berktas M, Asli K, Fehmi A (2016) Bedside Alarmin: Neutrophil-to-Lymphocyte Ratio in Acute Kidney Injury. J Nephrol Ther 6:251. doi:10.4172/2161-0959.1000251

Copyright: © 2016 Bozkurt D, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License; which permits unrestricted use; distribution; and reproduction in any medium; provided the original author and source are credited.

Visit for more related articles at Journal of Nephrology & Therapeutics

Abstract

mphocyte ratio (NLR) is novel prognostic marker in various inflammatory conditions. We performed a retrospective study investigating whether NLR has prognostic significance in patients suffered from AKI. Materias and Methods: Two hundred and ninety five AKI patients were evaluated retrospectively. Baseline values on admission, final values at discharge and after discharging during follow-up period in outpatient clinic until six months to one year were recorded. Results: It has been shown that, final NLR and timely changed NLR during hospital course are significant mortality predictors in AKI patients both in univariate and mutually adjusted multivariate logistic regression analysis. To predict mortality, we showed that, level of 9.90 point for final NLR has 73% sensitivity and 87% specifity as compared to value below in ROC analysis (HR: 7.31, CI 3.36-15.91; p < 0.001). Conclusion: NLR can be a novel screening tool for AKI patients during their hospital course

Keywords

Acute kidney injury; Neutrophil lymphocyte count; Mortality

Introduction

Acute renal failure, currently named as acute kidney injury (AKI); is one of the most leading cause of cardiovascular failure, infections, morbidity and mortality in intensive care unit (ICU) patients. AKI, especially requiring hemodialysis represents a condition directly effect patient’s survival. AKI represents a systemic inflammatory condition. AKI shows direct cause and effect relationship with inflammation [1-3]. An easily measurable parameter, ratio of neutrophil and lymphocyte counts (NLR), is the novel inflammatory marker in various clinical conditions also which can be used as an indicator of systemic inflammation [4]. Indeed, NLR has been shown to predict outcomes in various clinical conditions including, peripheral vascular disease, end stage renal disease and critically ill patients [5-7]. Therefore, predicting increased mortality and morbidity in AKI is not surprising.

As suggested above AKI is an inflammatory disorder and NLR is a marker of inflammation. Thus it is possible that NLR may have prognostic significance in AKI. Thus this study is performed to investigate whether NLR has a prognostic significance in our pilot case-control study.

Materials and Method

Study population

In this retrospective report, between January 2010 and December 2012, N17 ICD coded patients (considered as acute renal failure, n=295) were recruited. The flow chart of the patients was shown in Figure 1.

Nephrology-Therapeutics-Study-population

Figure 1: Study population flow chart.

AKI was staged and defined with the guidance of KDIGO-CPGAKI Criteria [8]. Definition was set under the scope of any of the following:

1. Increase in serum creatinine by ≥ 0.3 mg/dl within 48 hours or

2. Increase in serum creatinine to ≥ 1.5 times baseline, which is known or presumed to have occured within the prior 7 days or

3. Urine volume < 0.5 ml/kg/h for 6 hours.

Reasons for entering dialysis on admission and during the hospital course were recorded. All patients requiring dialysis were evaluated and managed by the same team of nephrologists and ICU practitioner. Prescribed dialysis modes were daily conventional dialysis with or without ultrafiltration. Demographical properties such as age, sex, reason for admission and comorbid clinical ilnessess with previous medical history was recorded. Non traditional inflammation marker, NLR, routine serum biochemical analysis and complete blood count were recorded. Records at baseline (baseline), at discharge (final) and after discharging during outpatient clinic follow-up (last follow-up, 6 months to one year after discharging) were included in statistical analysis). Timely NLR change between admission and final, calculated as follow: [(Final NLR-Baseline NLR)/hospital stay in days)]. To estimate kidney function, the most recently advocated formula of Modification of Diet in Renal Disease Study Group (MDRD-eGFR) [9] was used. The predictors of all cause mortality were examined.

The need for informed consent was waived by the institutional review board.

Statistical Analysis

Categorical variables are summarized count, percentage whereas continuous ones are summarized mean, standard deviation, median, interquartile range, minimum and maximum as appropriate. Cox proportional-hazards regression model and mutually adjusted multivariate regression analysis were used to determine the effects of independent parameters on mortality. ROC analysis was performed to determine cut-off values for final NLR level and timely changed NLR ratios during hospital course. Overall significance level is 5%. IBM SPSS ver 21.0 is used for analyses.

Results

Of 295 eligible acute renal failures, N17 ICD coded patients admitted to internal medicine intensive care unit, 201 patients, was recruited into retrospective cohort study. Sixteen patients have previous renal disease, other than stage 3 or more. Eighty one patients have diabetes mellitus with 33 of them had been required insulin treatment. Baseline characteristics of study population were summarized in Figure 2.

Nephrology-Therapeutics-Study-cohort

Figure 2: Study cohort baseline charecteristics.

According to univariate analysis, being older than 65 years old, having CVD history and infection related AKI, decreased level of serum albumin on admission and inotrope usage were independent mortality predictors. At discharge, increased level of WBC, uric acid level, NLR, MPV, lymphocyte count, CRP and serum creatinine levels as compared to baseline were independent mortality predictors Figure 3.

Nephrology-Therapeutics-Univariate-analysis

Figure 3: Univariate analysis of mortality predictors.

Mutually adjusted multiple logistic regression analysis was also performed with significant mortality predictors of univariate analysis as shown in Figure 4. Increment in timely changed NLR and serum creatinine levels were independent mortality predictors in our AKI cohort (Figure 4).

Nephrology-Therapeutics-Mutually-adjused

Figure 4: Mutually adjused multiple logistic regression analysis of mortality predictors.

Non traditional predictor of systemic inflammation, NLR, at the end of ICU course was independent predictor of mortality (HR: 7.80, CI 3.77-16.15; p<0.001). To determine cut-off value for final NLR, ROC analysis was performed. Level of 9.90 point for final NLR has 73% sensitivity and 87% specifity. The value for final NLR level above the median (=10) was significant mortality predictor as compared to value below (HR: 7.31, CI 3.36-15.91; p<0.001). Timely changed NLR(ΔNLR) was significant (HR:7.41, CI 3.60-13.26; p<0.001) mortality predictor. Timely change in absolute NLR, even considered last to follow-up values were significantly associated with mortality. In infection related AKI group (n =112), timely changed NLR was also significant mortality predictor (HR: 31.77, CI 1.14-4.05; p = 0.018) (Figure 5).

Nephrology-Therapeutics-Timely-changed

Figure 5: Timely changed LNR in study population.

Conclusion

We conducted a retrospective analysis included 201 ICU admission due to acute kidney injury. This is the first study in literature evaluating the effects of NLR on outcome mainly mortality in AKI population. As a result we have demonstrated that insulin required diabetes mellitus (2.18, 1.08-4.4, p = 0.030, data not shown), infection related AKI, decreased albumin levels, CVD history, inotrope usage and aging were mortality predictors. We also showed that, increment in serum creatinine level and timely changed NLR were also independent mortality predictorsin mutually adjusted multivariate logistic regression analysis.

Incidence of AKI in worldwide is steadily increasing. AKI associates directly with longevity of hospital duration, patients’ mortality and development or progression of preexistent kidney disease9. Therefore, AKI has great socioeconomic and public health burden. Ischeamiareperfusion injury, sepsis and nephrotoxicity are the leading cause of this entity. Especially in elderly population, as in our cohort population, sepsis is the leading cause of all AKI cases [10-16].

After polytrauma, major surgical procedures or sepsis, marked neutrophilia and a lymphocytopenia are well known laboratory anormalities. Correlation between the severity of clinical course and the grade of neutrophilia and lymphocytopenia is well established in clinical settings [17]. Sepsis is the leading cause of AKI and carries high mortality rates. Increased generalized inflammation and inflammation in kidney during sepsis is not surprised. From that point of view it has been reported that the kidney endothelial cells and tubular cells play an active role in inflammatory process [18].Recent studies have demonstrated that inflammation-based prognostic scores are useful in predicting cardiovascular risk. An easy measurable laboratory test, NLR, was also reported in various cardiovascular diseases. The association between NLR and mortality has been showed previously in coronary artery diseases, coronary calcification scores, arterial stiffness, myocardial infarction, cerebrovascular accidents and cardiac syndrome X [19-26]. NLR was also examined in patients with renal failure. More recently increased NLR, above the median value, has been shown as a cardiovascular and overall mortality predictor in maintenance peritoneal dialysis patients [27]. In hemodialysis patients NLR was also correlated patients’ mortality. Median value >5/1 was associated mortality significantly as compared to value < 5/1 [28].

Final NLR and increment in timely changed NLR during hospital stay were significantly correlated with mortality. There was a steadily decrease NLR values pointed at baseline, final and last follow-up especially in mortal patients. Indeed we observed that there was lowest NLR value recordings as compared to value of admission in alive patients. This seems to be important, NLR change during hospital course may be screening tool for patients’ outcome. Above the median value, 10/1, as compared to value < 10/1 was significantly better mortality predictor. ROC analysis revealed cut-off value for final NLR is 9.90 which has 73% sensitivity and 87% specifity. Change in NLR timely and change in percent NLR as compared to baseline were also significant predictor of mortality. These were the first detected NLR values predicting mortality in AKI.

MPV and Lymphocyte count change during ICU course are the novel tools for predicting mortality [29,30]. Our study has also showed that final MPV and Lymhocyte counts were mortality predictors. Although this relationship has not reached statistical significance in multivariate regression analysis, this might be clear in larger retrospective populations or prospective designs. Besides NLR, MPV and lymphocyte counts are also cheaper and easily measurable laboratory values which reflect patients’ prognosis.

There are several limitations. This is the pilot study which is performed on retrospective cohort evaluating the impact of NLR on mortality in AKI. Single centre experience which can result in selection bias is another point of view. Our institute has seven ICU affiliations such as Anesthesiology and Reanimation, Chest Disease, Cardiology, Cardiovascular Surgery, General Surgery and Emergency Department ICUs. Highly selected population, representing only internal medicine ICU admissions, were evaluated. Therefore, it is important to realize that our findings may not be applicable to all ICU patients suffering from AKI due to the other types of causes. We only considered the development of AKI on admission rather than the development of AKI later in the hospital course. Patients were examined during ICU stay and until six months after hospital discharge. This scenario may represent the limited patients and time interval for analyzing outcome predictors of AKI. Under the scope of this point of view, we started to analysis of whole ICU population retrospectively and then will prepare a prospective design.

In conclusion, using NLR as a screening tool in AKI management may possess some advantages for clinicians. During the course of AKI, an alarming increase or lack of descent in NLR as compared to baseline, clinician should be focused on taking preventive modalities otherwise mortality is inevitable. Although it is necessary to evaluate NLR on more patients coming from other ICU departments in randomised controlled trials, we speculate that NLR can be a bedside alarmin, a screening tool, for patients suffered from AKI.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 8406
  • [From(publication date):
    June-2016 - Nov 23, 2017]
  • Breakdown by view type
  • HTML page views : 8310
  • PDF downloads : 96
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords